MicroRNA differently expressed in HCV-associated DLBCL versus DLBCL and versus HCV-positive germinal centre B cells
| miR name | Genomic location* | HCV-associated DLBCL | DLBCL | HCV+ B cells | FC HCV+DLBCL/ DLBCL | FC HCV+DLBCL/ HCV+ B Cells | Number of validated target† |
|---|---|---|---|---|---|---|---|
| miR-363-5p | Xq26.2 | 0.33 | 3.27 | 24.99 | 0.10 | 0.01 | – |
| miR-20b-3p | Xq26.2 | 0.22 | 1.57 | 3.41 | 0.14 | 0.06 | – |
| miR-424-3p | Xq26.3 | 0.57 | 2.21 | 0.028 | 0.26 | 20.36 | – |
The geometrical mean of the miRNA expression is provided.
*According to miRbase (http://www.mirbase.org/).
†According to tarbase 6.0 (http://diana.imis.athena-innovation.gr/).
DLBCL, diffuse large B-cell lymphoma; FC, fold-change; HCV, hepatitis C virus.